These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 37864340)

  • 1. Performance Effect of Adjusting Insulin Sensitivity for Model-Based Automated Insulin Delivery Systems.
    Moscoso-Vasquez M; Fabris C; Breton MD
    J Diabetes Sci Technol; 2023 Nov; 17(6):1470-1481. PubMed ID: 37864340
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Enhancing automatic closed-loop glucose control in type 1 diabetes with an adaptive meal bolus calculator - in silico evaluation under intra-day variability.
    Herrero P; Bondia J; Adewuyi O; Pesl P; El-Sharkawy M; Reddy M; Toumazou C; Oliver N; Georgiou P
    Comput Methods Programs Biomed; 2017 Jul; 146():125-131. PubMed ID: 28688482
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Continuous Glucose Monitors and Activity Trackers to Inform Insulin Dosing in Type 1 Diabetes: The University of Virginia Contribution.
    Fabris C; Ozaslan B; Breton MD
    Sensors (Basel); 2019 Dec; 19(24):. PubMed ID: 31817678
    [No Abstract]   [Full Text] [Related]  

  • 4. Zone model predictive control: a strategy to minimize hyper- and hypoglycemic events.
    Grosman B; Dassau E; Zisser HC; Jovanovic L; Doyle FJ
    J Diabetes Sci Technol; 2010 Jul; 4(4):961-75. PubMed ID: 20663463
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Overnight closed-loop insulin delivery with model predictive control: assessment of hypoglycemia and hyperglycemia risk using simulation studies.
    Wilinska ME; Budiman ES; Taub MB; Elleri D; Allen JM; Acerini CL; Dunger DB; Hovorka R
    J Diabetes Sci Technol; 2009 Sep; 3(5):1109-20. PubMed ID: 20144424
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intermittent closed-loop blood glucose control for people with type 1 diabetes on multiple daily injections.
    Estremera E; Beneyto A; Cabrera A; Contreras I; Vehí J
    Comput Methods Programs Biomed; 2023 Jun; 236():107568. PubMed ID: 37137221
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Simulation-driven optimization of insulin therapy profiles in a commercial hybrid closed-loop system.
    Diaz C JL; Villa-Tamayo MF; Moscoso-Vasquez M; Colmegna P
    Comput Methods Programs Biomed; 2023 Dec; 242():107830. PubMed ID: 37806122
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Zone-MPC Automated Insulin Delivery Algorithm Tuned for Pregnancy Complicated by Type 1 Diabetes.
    Ozaslan B; Deshpande S; Doyle FJ; Dassau E
    Front Endocrinol (Lausanne); 2021; 12():768639. PubMed ID: 35392357
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sensitivity of the Predictive Hypoglycemia Minimizer System to the Algorithm Aggressiveness Factor.
    Finan DA; Dassau E; Breton MD; Patek SD; McCann TW; Kovatchev BP; Doyle FJ; Levy BL; Venugopalan R
    J Diabetes Sci Technol; 2015 Jun; 10(1):104-10. PubMed ID: 26134834
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A Comparison of Postprandial Glucose Control in the Medtronic Advanced Hybrid Closed-Loop System Versus 670G.
    Weinzimer SA; Bailey RJ; Bergenstal RM; Nimri R; Beck RW; Schatz D; Ambler-Osborn L; Schweiger DS; von dem Berge T; Sibayan J; Johnson ML; Calhoun P; Phillip M;
    Diabetes Technol Ther; 2022 Aug; 24(8):573-582. PubMed ID: 35363054
    [No Abstract]   [Full Text] [Related]  

  • 11. In Silico Analysis of an Exercise-Safe Artificial Pancreas With Multistage Model Predictive Control and Insulin Safety System.
    Garcia-Tirado J; Colmegna P; Corbett JP; Ozaslan B; Breton MD
    J Diabetes Sci Technol; 2019 Nov; 13(6):1054-1064. PubMed ID: 31679400
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Assessment of Meal Anticipation for Improving Fully Automated Insulin Delivery in Adults With Type 1 Diabetes.
    Garcia-Tirado J; Colmegna P; Villard O; Diaz JL; Esquivel-Zuniga R; Koravi CLK; Barnett CL; Oliveri MC; Fuller M; Brown SA; DeBoer MD; Breton MD
    Diabetes Care; 2023 Sep; 46(9):1652-1658. PubMed ID: 37478323
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Internal model control based module for the elimination of meal and exercise announcements in hybrid artificial pancreas systems.
    Sala-Mira I; Garcia P; Díez JL; Bondia J
    Comput Methods Programs Biomed; 2022 Nov; 226():107061. PubMed ID: 36116400
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Study protocol for a randomised open-label clinical trial examining the safety and efficacy of the Android Artificial Pancreas System (AAPS) with advanced bolus-free features in adults with type 1 diabetes: the 'CLOSE IT' (Closed Loop Open SourcE In Type 1 diabetes) trial.
    Wilkinson T; Tomic D; Boyle E; Burren D; Elghattis Y; Jenkins A; Keesing C; Middleton S; Nanayakkara N; Williman J; de Bock M; Cohen ND
    BMJ Open; 2024 Feb; 14(2):e078171. PubMed ID: 38382954
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Use of a Smart Bolus Calculator Informed by Real-time Insulin Sensitivity Assessments Reduces Postprandial Hypoglycemia Following an Aerobic Exercise Session in Individuals With Type 1 Diabetes.
    Fabris C; Nass RM; Pinnata J; Carr KA; Koravi CLK; Barnett CL; Oliveri MC; Anderson SM; Chernavvsky DR; Breton MD
    Diabetes Care; 2020 Apr; 43(4):799-805. PubMed ID: 32144167
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Integration of a Safety Module to Prevent Rebound Hypoglycemia in Closed-Loop Artificial Pancreas Systems.
    Villa-Tamayo MF; Colmegna P; Breton MD
    J Diabetes Sci Technol; 2024 Mar; 18(2):318-323. PubMed ID: 37966051
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Incorporating Prior Information in Adaptive Model Predictive Control for Multivariable Artificial Pancreas Systems.
    Sun X; Rashid M; Hobbs N; Brandt R; Askari MR; Cinar A
    J Diabetes Sci Technol; 2022 Jan; 16(1):19-28. PubMed ID: 34861777
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Closed-loop artificial pancreas using subcutaneous glucose sensing and insulin delivery and a model predictive control algorithm: the Virginia experience.
    Clarke WL; Anderson S; Breton M; Patek S; Kashmer L; Kovatchev B
    J Diabetes Sci Technol; 2009 Sep; 3(5):1031-8. PubMed ID: 20144416
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Health Economics of Automated Insulin Delivery Systems and the Potential Use of Time in Range in Diabetes Modeling: A Narrative Review.
    Mathieu C; Ahmed W; Gillard P; Cohen O; Vigersky R; de Portu S; Ozdemir Saltik AZ
    Diabetes Technol Ther; 2024 Mar; 26(S3):66-75. PubMed ID: 38377319
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A closed-loop artificial pancreas based on risk management.
    Cameron F; Bequette BW; Wilson DM; Buckingham BA; Lee H; Niemeyer G
    J Diabetes Sci Technol; 2011 Mar; 5(2):368-79. PubMed ID: 21527108
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.